In the present study, we demonstrated that t(6;8) caused the mutant-allele super-enhancer of RUNX2 (seRUNX2der8) to activate the expression of MYC and promote the formation of BPDCN. Here, RUNX2 is linked to CD4+/CD56+ hematodermic neoplasm.